Published in J Alzheimers Dis on January 01, 2011
Altered neuroinflammatory, arachidonic acid cascade and synaptic markers in postmortem Alzheimer's disease brain. Transl Psychiatry (2011) 1.08
Lipidomics of Alzheimer's disease: current status. Alzheimers Res Ther (2012) 0.92
Altered fatty acid concentrations in prefrontal cortex of schizophrenic patients. J Psychiatr Res (2013) 0.90
Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers. Int J Mol Sci (2013) 0.90
Peroxisomes in brain development and function. Biochim Biophys Acta (2015) 0.88
Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans. Brain Res Bull (2011) 0.86
Translational studies on regulation of brain docosahexaenoic acid (DHA) metabolism in vivo. Prostaglandins Leukot Essent Fatty Acids (2012) 0.83
Docosahexaenoic Acid and Cognition throughout the Lifespan. Nutrients (2016) 0.82
Integrating cytosolic phospholipase A₂ with oxidative/nitrosative signaling pathways in neurons: a novel therapeutic strategy for AD. Mol Neurobiol (2012) 0.79
Coordination of gene expression of arachidonic and docosahexaenoic acid cascade enzymes during human brain development and aging. PLoS One (2014) 0.78
Alterations in Lipid Levels of Mitochondrial Membranes Induced by Amyloid-β: A Protective Role of Melatonin. Int J Alzheimers Dis (2012) 0.78
Choline plasmalogens isolated from swine liver inhibit hepatoma cell proliferation associated with caveolin-1/Akt signaling. PLoS One (2013) 0.76
Dietary DHA supplementation causes selective changes in phospholipids from different brain regions in both wild type mice and the Tg2576 mouse model of Alzheimer's disease. Biochim Biophys Acta (2016) 0.76
APP Function and Lipids: A Bidirectional Link. Front Mol Neurosci (2017) 0.75
PPAR- γ impairment alters peroxisome functionality in primary astrocyte cell cultures. Biomed Res Int (2014) 0.75
The phospholipid composition of the human entorhinal cortex remains relatively stable over 80 years of adult aging. Geroscience (2017) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem (1957) 173.99
Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol (1991) 14.25
Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids (1970) 11.81
Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol (1990) 6.79
Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem (1994) 4.35
Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proc Natl Acad Sci U S A (2001) 4.26
Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol (2003) 3.56
A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest (2005) 3.44
Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron (2004) 3.21
NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies. Neurobiol Aging (2006) 2.55
The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett (1995) 2.35
Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry. J Neurochem (2001) 1.98
Synaptic degeneration in Alzheimer's disease. Acta Neuropathol (2009) 1.93
Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. J Lipid Res (2003) 1.92
Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids (1991) 1.90
Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer's disease supports retrogenesis. Neuroimage (2008) 1.87
Evidence for a membrane defect in Alzheimer disease brain. Proc Natl Acad Sci U S A (1992) 1.86
Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am J Clin Nutr (1994) 1.77
Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy. J Alzheimers Dis (2010) 1.68
Fish, meat, and risk of dementia: cohort study. BMJ (2002) 1.66
Lipids of nervous tissue: composition and metabolism. Prog Lipid Res (1985) 1.66
Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids (2000) 1.64
Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling. Neurochem Res (2004) 1.64
Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry (2009) 1.64
The biochemistry of plasmalogens. I. Isolation and characterization of phosphatidal choline, a pure native plasmalogen. J Biol Chem (1962) 1.58
Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem Res (1998) 1.57
One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats. J Lipid Res (2005) 1.54
A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis. Brain Res Brain Res Rev (1993) 1.51
Dietary n-3 PUFA deprivation for 15 weeks upregulates elongase and desaturase expression in rat liver but not brain. J Lipid Res (2007) 1.48
Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia. J Lipid Res (2007) 1.48
Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study. Br J Nutr (2003) 1.46
Half-lives of docosahexaenoic acid in rat brain phospholipids are prolonged by 15 weeks of nutritional deprivation of n-3 polyunsaturated fatty acids. J Neurochem (2004) 1.42
Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II). J Neurochem (1994) 1.38
Loss of proteins regulating synaptic plasticity in normal aging of the human brain and in Alzheimer disease. J Neuropathol Exp Neurol (1999) 1.37
Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients. Neurobiol Dis (2009) 1.35
Imaging neuroinflammation in Alzheimer's disease with radiolabeled arachidonic acid and PET. J Nucl Med (2008) 1.32
Bipolar disorder and mechanisms of action of mood stabilizers. Brain Res Rev (2009) 1.31
Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease. J Neuroinflammation (2006) 1.20
Quantitative analysis of simple lipid classes by thin-layer chromatography. Biochim Biophys Acta (1968) 1.20
Arachidonic acid and the brain. J Nutr (2008) 1.19
Plasmalogens: workhorse lipids of membranes in normal and injured neurons and glia. Neuroscientist (2001) 1.16
Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients. Mol Psychiatry (2009) 1.14
Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain. Brain Res (1995) 1.14
Lipid composition of synaptic plasma membranes isolated from rat brain by zonal centrifugation. Biochemistry (1969) 1.13
Fish, docosahexaenoic acid and Alzheimer's disease. Prog Lipid Res (2009) 1.11
Global measures: utility in defining and measuring treatment response in dementia. Int Psychogeriatr (2007) 1.10
Relation between free fatty acid and acyl-CoA concentrations in rat brain following decapitation. Neurochem Res (1997) 1.10
Lipid composition in different regions of the brain in Alzheimer's disease/senile dementia of Alzheimer's type. J Neurochem (1992) 1.09
Neural membrane phospholipids in Alzheimer disease. Neurochem Res (1995) 1.09
Nutritional factors and risk of incident dementia in the PAQUID longitudinal cohort. J Nutr Health Aging (2004) 1.08
Phospholipid composition and levels are altered in Down syndrome brain. Brain Res (2000) 1.08
Brain lipid concentrations in bipolar disorder. J Psychiatr Res (2009) 1.06
Omega-3 fatty acids and risk of dementia: the Canadian Study of Health and Aging. Am J Clin Nutr (2009) 1.02
Differential changes in synaptic proteins in the Alzheimer frontal cortex with marked increase in PSD-95 postsynaptic protein. J Alzheimers Dis (2008) 1.01
Deacylation-reacylation of arachidonoyl groups in cerebral phospholipids. Ann N Y Acad Sci (1989) 1.01
Fatty acid composition of frontal, temporal and parietal neocortex in the normal human brain and in Alzheimer's disease. Neurochem Res (2009) 1.00
Protecting the synapse: evidence for a rational strategy to treat HIV-1 associated neurologic disease. J Neuroimmune Pharmacol (2006) 0.99
Severe deficiency of docosahexaenoic acid in peroxisomal disorders: a defect of delta 4 desaturation? Neurology (1990) 0.97
Cytosolic phospholipase A2 is induced in reactive glia following different forms of neurodegeneration. Glia (1999) 0.95
High-resolution PET studies in Alzheimer's disease. Neuropsychopharmacology (1991) 0.94
Examination of the validity of the hierarchical model of neuropathological staging in normal aging and Alzheimer's disease. Acta Neuropathol (1998) 0.94
The synaptic organization of the neocortex in Alzheimer's disease. Med Hypotheses (1993) 0.93
Abnormal content of n-6 and n-3 long-chain unsaturated fatty acids in the phosphoglycerides and cholesterol esters of parahippocampal cortex from Alzheimer's disease patients and its relationship to acetyl CoA content. Int J Biochem Cell Biol (1998) 0.93
Membrane components separate early-onset Alzheimer's disease from senile dementia of the Alzheimer type. Int Psychogeriatr (1996) 0.93
Activation of phospholipase A2 by amyloid beta-peptides in vitro. Biochemistry (1996) 0.91
Concentration and fatty acid composition of cholesteryl esters of normal human brain. J Neurochem (1969) 0.90
Phospholipid profile in the postmortem hippocampus of patients with schizophrenia and bipolar disorder: no changes in docosahexaenoic acid species. J Psychiatr Res (2010) 0.89
Rapid synthesis and turnover of brain microsomal ether phospholipids in the adult rat. J Lipid Res (2002) 0.89
A frontal variant of Alzheimer's disease exhibits decreased calcium-independent phospholipase A2 activity in the prefrontal cortex. Neurochem Int (2000) 0.89
Molecular insights into neurodevelopmental and neurodegenerative diseases. Brain Res Bull (2000) 0.86
Evidence for a diffusional model of Alzheimer amyloid A4 (beta-amyloid) deposition during neuritic plaque formation. Neuroscience (1989) 0.85
Synapse formation is enhanced by oral administration of uridine and DHA, the circulating precursors of brain phosphatides. J Nutr Health Aging (2009) 0.85
Analysis of phospholipid molecular species in brain by (31)P NMR spectroscopy. Magn Reson Med (2000) 0.84
Dietary low linolenic acid compared with docosahexaenoic acid alter synaptic plasma membrane phospholipid fatty acid composition and sodium-potassium ATPase kinetics in developing rats. J Neurochem (2002) 0.84
Altered brain lipid composition in cyclooxygenase-2 knockout mouse. J Lipid Res (2007) 0.83
Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia? Curr Opin Clin Nutr Metab Care (2010) 0.82
Regional specificity of membrane instability in Alzheimer's disease brain. Brain Res (1993) 0.81
Membrane fatty acid composition shows delta-6-desaturase abnormalities in Alzheimer's disease. Neuroreport (1990) 0.80
Reductions in membrane proteins and lipids in basal ganglia of classic Alzheimer disease patients. Alzheimer Dis Assoc Disord (1996) 0.78
Docosahexaenoic acid and amyloid-beta peptide signaling in Alzheimer's disease. World Rev Nutr Diet (2009) 0.78
Multiple biochemical deficits in both gray and white matter of Alzheimer brains. Prog Neuropsychopharmacol Biol Psychiatry (1986) 0.76
Positions of double bonds in the monounsaturated alk-1-enyl groups from the plasmalogens of human heart and brain. Chem Phys Lipids (1971) 0.76
Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet (2009) 6.42
Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies. Am J Psychiatry (2002) 3.20
Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. J Clin Oncol (2006) 2.86
Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride. J Hepatol (2010) 2.65
SCLERAL AND CHOROIDAL THICKNESS IN SECONDARY HIGH AXIAL MYOPIA. Retina (2016) 2.28
Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr Microbiol (2010) 1.92
Prevalence of prehypertension and hypertension in a Chinese rural area from 1991 to 2007. Hypertens Res (2010) 1.90
Brain fuel metabolism, aging, and Alzheimer's disease. Nutrition (2010) 1.89
Adolescent behavior and dopamine availability are uniquely sensitive to dietary omega-3 fatty acid deficiency. Biol Psychiatry (2013) 1.67
Mammographic parenchymal patterns and self-reported soy intake in Singapore Chinese women. Cancer Epidemiol Biomarkers Prev (2002) 1.67
Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy. J Am Coll Cardiol (2012) 1.64
Comparative evaluation of quercetin, isoquercetin and rutin as inhibitors of alpha-glucosidase. J Agric Food Chem (2009) 1.63
Wt1 negatively regulates beta-catenin signaling during testis development. Development (2008) 1.61
Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder. Prostaglandins Leukot Essent Fatty Acids (2009) 1.54
One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats. J Lipid Res (2005) 1.54
Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin Cancer Res (2002) 1.53
Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein. Sci Transl Med (2014) 1.52
Cancer patients' preferences for communication of unfavourable news: an Asian perspective. Support Care Cancer (2006) 1.52
The Wilms tumor gene, Wt1, is critical for mouse spermatogenesis via regulation of sertoli cell polarity and is associated with non-obstructive azoospermia in humans. PLoS Genet (2013) 1.52
A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice. J Immunol (2010) 1.51
Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver. Prostaglandins Leukot Essent Fatty Acids (2007) 1.50
Meta-analysis followed by replication identifies loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as associated with systemic lupus erythematosus in Asians. Am J Hum Genet (2012) 1.49
Aspirin resistance in off-pump coronary artery bypass grafting. Eur J Cardiothorac Surg (2012) 1.49
Diffusion on a Curved Surface Coupled to Diffusion in the Volume: Application to Cell Biology. J Comput Phys (2007) 1.49
Dietary n-3 PUFA deprivation for 15 weeks upregulates elongase and desaturase expression in rat liver but not brain. J Lipid Res (2007) 1.48
Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry. Brain (2004) 1.45
Progression of corpus callosum atrophy in Alzheimer disease. Arch Neurol (2002) 1.44
Half-lives of docosahexaenoic acid in rat brain phospholipids are prolonged by 15 weeks of nutritional deprivation of n-3 polyunsaturated fatty acids. J Neurochem (2004) 1.42
Rapamycin affects tissue plasminogen activator and plasminogen activator inhibitor I expression: a potential prothrombotic mechanism of drug-eluting stents. Angiology (2011) 1.42
Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231. Arch Neurol (2002) 1.41
[Effect analysis of multi-electrode synchronous radiofrequency ablation and conventional single electrode overlapping ablation]. Zhonghua Yi Xue Za Zhi (2015) 1.38
Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease. Neurobiol Aging (2002) 1.35
Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients. Neurobiol Dis (2009) 1.35
Rat brain arachidonic acid metabolism is increased by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide. J Neurochem (2004) 1.33
Emodin enhances arsenic trioxide-induced apoptosis via generation of reactive oxygen species and inhibition of survival signaling. Cancer Res (2004) 1.33
Imaging neuroinflammation in Alzheimer's disease with radiolabeled arachidonic acid and PET. J Nucl Med (2008) 1.32
Bipolar disorder and mechanisms of action of mood stabilizers. Brain Res Rev (2009) 1.31
Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat. J Immunol (2012) 1.31
De novo sequencing and analysis of root transcriptome using 454 pyrosequencing to discover putative genes associated with drought tolerance in Ammopiptanthus mongolicus. BMC Genomics (2012) 1.29
Brain elongation of linoleic acid is a negligible source of the arachidonate in brain phospholipids of adult rats. Biochim Biophys Acta (2006) 1.28
Regional network of magnetic resonance imaging gray matter volume in healthy aging. Neuroreport (2006) 1.27
Lipid and lipid mediator profiling of human synovial fluid in rheumatoid arthritis patients by means of LC-MS/MS. Biochim Biophys Acta (2012) 1.27
Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats. Neuropsychopharmacology (2005) 1.26
Lamina cribrosa and peripapillary sclera histomorphometry in normal and advanced glaucomatous Chinese eyes with various axial length. Invest Ophthalmol Vis Sci (2009) 1.26
Brain incorporation of 11C-arachidonic acid, blood volume, and blood flow in healthy aging: a study with partial-volume correction. J Nucl Med (2004) 1.25
Use of calcium and magnesium infusions in prevention of oxaliplatin induced sensory neuropathy. Asia Pac J Clin Oncol (2010) 1.24
Docosahexaenoic acid synthesis from alpha-linolenic acid by rat brain is unaffected by dietary n-3 PUFA deprivation. J Lipid Res (2007) 1.23
Age-related networks of regional covariance in MRI gray matter: reproducible multivariate patterns in healthy aging. Neuroimage (2009) 1.23
alpha-Linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid. J Neurochem (2005) 1.23
Inhibition of NADPH oxidase promotes alternative and anti-inflammatory microglial activation during neuroinflammation. J Neurochem (2011) 1.22
Specialized proresolving mediators enhance human B cell differentiation to antibody-secreting cells. J Immunol (2012) 1.20
High prevalence of a novel porcine bocavirus in weanling piglets with respiratory tract symptoms in China. Arch Virol (2010) 1.20
Relation of corpus callosum and hippocampal size to age in nondemented adults with Down's syndrome. Am J Psychiatry (2003) 1.19
Rapid high-energy microwave fixation is required to determine the anandamide (N-arachidonoylethanolamine) concentration of rat brain. Neurochem Res (2005) 1.19
Double restriction-enzyme digestion improves the coverage and accuracy of genome-wide CpG methylation profiling by reduced representation bisulfite sequencing. BMC Genomics (2013) 1.18
Brain lipid metabolism in the cPLA2 knockout mouse. J Lipid Res (2003) 1.18
The calmodulin-binding protein kinase 3 is part of heat-shock signal transduction in Arabidopsis thaliana. Plant J (2008) 1.18
Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation. J Clin Invest (2010) 1.17
Differential DNA methylation in discrete developmental stages of the parasitic nematode Trichinella spiralis. Genome Biol (2012) 1.16
Chronic NMDA administration to rats up-regulates frontal cortex cytosolic phospholipase A2 and its transcription factor, activator protein-2. J Neurochem (2007) 1.16
Formation of eicosanoids, E2/D2 isoprostanes, and docosanoids following decapitation-induced ischemia, measured in high-energy-microwaved rat brain. J Lipid Res (2008) 1.16
SENP3-mediated de-conjugation of SUMO2/3 from promyelocytic leukemia is correlated with accelerated cell proliferation under mild oxidative stress. J Biol Chem (2010) 1.16
Structural basis of SspB-tail recognition by the zinc binding domain of ClpX. J Mol Biol (2007) 1.15
Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography. J Lipid Res (2008) 1.14
Epigenetics and SLE: RFX1 downregulation causes CD11a and CD70 overexpression by altering epigenetic modifications in lupus CD4+ T cells. J Autoimmun (2010) 1.14
Upregulated liver conversion of alpha-linolenic acid to docosahexaenoic acid in rats on a 15 week n-3 PUFA-deficient diet. J Lipid Res (2006) 1.13
The Arabidopsis resistance-like gene SNC1 is activated by mutations in SRFR1 and contributes to resistance to the bacterial effector AvrRps4. PLoS Pathog (2010) 1.13
Chronic lithium administration attenuates up-regulated brain arachidonic acid metabolism in a rat model of neuroinflammation. J Neurochem (2007) 1.13
Risk factors for breast cancer associated with mammographic features in Singaporean chinese women. Cancer Epidemiol Biomarkers Prev (2004) 1.12
Overexpression of the growth arrest and DNA damage-induced 45alpha gene contributes to autoimmunity by promoting DNA demethylation in lupus T cells. Arthritis Rheum (2010) 1.12
Vitamin E deficiency enhances pulmonary inflammatory response and oxidative stress induced by single-walled carbon nanotubes in C57BL/6 mice. Toxicol Appl Pharmacol (2007) 1.11
Rho kinase phosphorylation promotes ezrin-mediated metastasis in hepatocellular carcinoma. Cancer Res (2011) 1.11
ACE2 overexpression ameliorates left ventricular remodeling and dysfunction in a rat model of myocardial infarction. Hum Gene Ther (2010) 1.10
Age at diagnosis and the choice of survival analysis methods in cancer epidemiology. J Clin Epidemiol (2003) 1.10
Rat heart cannot synthesize docosahexaenoic acid from circulating alpha-linolenic acid because it lacks elongase-2. J Lipid Res (2008) 1.09
Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans. Prostaglandins Leukot Essent Fatty Acids (2012) 1.09
Brain incorporation of [11C]arachidonic acid in young healthy humans measured with positron emission tomography. J Cereb Blood Flow Metab (2002) 1.07
Chronic N-methyl-D-aspartate administration increases the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat. J Lipid Res (2007) 1.07
Retracted Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in brain of HIV-1 transgenic rats. J Neuroinflammation (2011) 1.06
Neuroinflammation and synaptic loss. Neurochem Res (2012) 1.06
Brain lipid concentrations in bipolar disorder. J Psychiatr Res (2009) 1.06
Valproic acid down-regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and -2 in rat brain. J Neurochem (2003) 1.05
Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition. Mol Med (2010) 1.05